A tumor-specific cellular environment at the brain invasion border of adamantinomatous craniopharyngiomas

Virchows Archiv

Volumn 456, Issue 3, 2010, Pages 287-300

  Burghaus, Stefanie ^a   Hölsken, Annett ^a   Buchfelder, Michael ^a   Fahlbusch, Rudolf ^b   Riederer, Beat M ^c   Hans, Volkmar ^d   Blümcke, Ingmar ^a   Buslei, Rolf ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b INTERNATIONAL NEUROSCIENCE INSTITUTE   (Germany)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

^d EVANGELISCHES KRANKENHAUS   (Germany)

Author keywords

Craniopharyngioma boundary; Immunofluorescence; Immunohistochemistry; MAP2; Neuropathology; Precursor cells

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; MICROTUBULE ASSOCIATED PROTEIN 2; NESTIN; TENASCIN; VIMENTIN; INTERMEDIATE FILAMENT PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; NERVE PROTEIN; TUMOR MARKER;

ADAMANTINOMATOUS CRANIOPHARYNGIOMA; ADOLESCENT; ADULT; AGED; ARTICLE; BRAIN TISSUE; CAVERNOUS HEMANGIOMA; CELL NUCLEUS; CELL POPULATION; CELL SPECIFICITY; CHILD; CONTROLLED STUDY; CRANIOPHARYNGIOMA; DIFFERENTIAL DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; METASTASIS; PAPILLARY CRANIOPHARYNGIOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SELLA TURCICA; TUMOR CELL; BRAIN; CANCER INVASION; GENE EXPRESSION REGULATION; HYPOPHYSIS TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; AGED; BRAIN; CHILD; CHILD, PRESCHOOL; CRANIOPHARYNGIOMA; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; INTERMEDIATE FILAMENT PROTEINS; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NERVE TISSUE PROTEINS; PITUITARY NEOPLASMS; TENASCIN; TUMOR MARKERS, BIOLOGICAL; VIMENTIN;

EID: 77949726669     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-009-0873-0     Document Type: Article

References (59)

1. GR Bunin TS Surawicz PA Witman, et al. 1998 The descriptive epidemiology of craniopharyngioma J Neurosurg 89 547 551 10.3171/jns.1998.89.4.0547 1:STN:280:DyaK1cvjt1Wqsw%3D%3D 9761047
2. J Kuratsu Y Ushio 1996 Epidemiological study of primary intracranial tumors in childhood. A population-based survey in Kumamoto Prefecture, Japan Pediatr Neurosurg 25 240 246 10.1159/000121132 1:STN:280:DyaK2svlsFChuw%3D%3D 9309787 discussion 247 (Pubitemid 27368935)
3. TE Adamson OD Wiestler P Kleihues, et al. 1990 Correlation of clinical and pathological features in surgically treated craniopharyngiomas J Neurosurg 73 12 17 10.3171/jns.1990.73.1.0012 1:STN:280:DyaK3c3nvVGiuw%3D%3D 2352012 (Pubitemid 20206378)
4. S Sekine T Shibata A Kokubu, et al. 2002 Craniopharyngiomas of adamantinomatous type harbor beta-catenin gene mutations Am J Pathol 161 1997 2001 1:CAS:528:DC%2BD38Xpslemtbg%3D 12466115 (Pubitemid 35434845)
5. K Kato Y Nakatani H Kanno, et al. 2004 Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma J Pathol 203 814 821 10.1002/path.1562 1:CAS:528:DC%2BD2cXmtFSmtLo%3D 15221941 (Pubitemid 38961568)
6. R Buslei M Nolde B Hofmann, et al. 2005 Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region Acta Neuropathol (Berl) 109 589 597 10.1007/s00401-005-1004-x 1:CAS:528:DC%2BD2MXls1Smsb8%3D (Pubitemid 40974148)
7. BM Hofmann J Kreutzer W Saeger, et al. 2006 Nuclear beta-catenin accumulation as reliable marker for the differentiation between cystic craniopharyngiomas and rathke cleft cysts: a clinico-pathologic approach Am J Surg Pathol 30 1595 1603 10.1097/01.pas.0000213328.64121.12 17122517 (Pubitemid 44808797)
8. P Kendall-Taylor PJ Jonsson R Abs, et al. 2005 The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma Eur J Endocrinol 152 557 567 10.1530/eje.1.01877 1:CAS:528:DC%2BD2MXjslans7s%3D 15817911 (Pubitemid 40575801)
9. N Karavitaki S Cudlip CB Adams, et al. 2006 Craniopharyngiomas Endocr Rev 27 371 397 10.1210/er.2006-0002 16543382 (Pubitemid 43848304)
10. H Gleeson R Amin M Maghnie 2008 'Do no harm': management of craniopharyngioma Eur J Endocrinol 159 Suppl 1 S95 S99 10.1530/EJE-08-0400 1:CAS:528:DC%2BD1MXhtFOnsbY%3D 18775978
11. HL Muller 2008 Childhood craniopharyngioma. Recent advances in diagnosis, treatment and follow-up Horm Res 69 193 202 10.1159/000113019 18204266 (Pubitemid 351562907)
12. R Fahlbusch BM Hofmann 2008 Surgical management of giant craniopharyngiomas Acta Neurochir (Wien) 150 1213 1226 10.1007/s00701-008-0137-9 1:STN:280:DC%2BD1cjps1WjtQ%3D%3D
13. T Kawamata O Kubo T Hori 2005 Histological findings at the boundary of craniopharyngiomas Brain Tumor Pathol 22 75 78 10.1007/s10014-005-0191-4 18095108 (Pubitemid 44576316)
14. R Fahlbusch J Honegger W Paulus, et al. 1999 Surgical treatment of craniopharyngiomas: experience with 168 patients J Neurosurg 90 237 250 10.3171/jns.1999.90.2.0237 1:STN:280:DyaK1M7jtl2qsQ%3D%3D 9950494 (Pubitemid 29068125)
15. HL Muller A Albanese G Calaminus, et al. 2006 Consensus and perspectives on treatment strategies in childhood craniopharyngioma: results of a meeting of the Craniopharyngioma Study Group (SIOP), Genova, 2004 J Pediatr Endocrinol Metab 19 Suppl 1 453 454 16700324
16. ML Garre A Cama 2007 Craniopharyngioma: modern concepts in pathogenesis and treatment Curr Opin Pediatr 19 471 479 10.1097/MOP.0b013e3282495a22 17630614 (Pubitemid 47075630)
17. S Puget M Garnett A Wray, et al. 2007 Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement J Neurosurg 106 3 12 17233305
18. U Lendahl LB Zimmerman RD McKay 1990 CNS stem cells express a new class of intermediate filament protein Cell 60 585 595 10.1016/0092-8674(90)90662-X 1:CAS:528:DyaK3cXkvFagsro%3D 1689217 (Pubitemid 20083815)
19. LC Wei M Shi LW Chen, et al. 2002 Nestin-containing cells express glial fibrillary acidic protein in the proliferative regions of central nervous system of postnatal developing and adult mice Brain Res Dev Brain Res 139 9 17 10.1016/S0165-3806(02)00509-6 1:CAS:528:DC%2BD38Xot1ajsLc%3D 12414089 (Pubitemid 35284675)
20. CA Messam J Hou JW Berman, et al. 2002 Analysis of the temporal expression of nestin in human fetal brain derived neuronal and glial progenitor cells Brain Res Dev Brain Res 134 87 92 10.1016/S0165-3806(01)00325-X 1:CAS:528:DC%2BD38Xis1OqtLc%3D 11947939 (Pubitemid 34310239)
21. K Sugawara H Kurihara M Negishi, et al. 2002 Nestin as a marker for proliferative endothelium in gliomas Lab Invest 82 345 351 1:CAS:528: DC%2BD38XivFOltrY%3D 11896213 (Pubitemid 34242527)
22. HP Erickson MA Bourdon 1989 Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors Annu Rev Cell Biol 5 71 92 10.1146/annurev.cb.05.110189.000443 1:CAS:528:DyaK3cXjtlOhug%3D%3D 2480799
23. H Gu S Wang CA Messam, et al. 2002 Distribution of nestin immunoreactivity in the normal adult human forebrain Brain Res 943 174 180 10.1016/S0006-8993(02)02615-X 1:CAS:528:DC%2BD38XkvFGrs78%3D 12101039 (Pubitemid 36120377)
24. A Joester A Faissner 2001 The structure and function of tenascins in the nervous system Matrix Biol 20 13 22 10.1016/S0945-053X(00)00136-0 1:CAS:528:DC%2BD3MXivVansrY%3D 11246000 (Pubitemid 32178103)
25. B Scheffler A Faissner H Beck, et al. 1997 Hippocampal loss of tenascin boundaries in Ammon's horn sclerosis Glia 19 35 46 10.1002/(SICI)1098- 1136(199701)19:1<35::AID-GLIA4>3.0.CO;2-9 1:STN:280:DyaK2s7ktlGmtw%3D%3D 8989566 (Pubitemid 27050448)
26. DA Reardon MR Zalutsky DD Bigner 2007 Antitenascin-C monoclonal antibody radioimmunotherapy for malignant glioma patients Expert Rev Anticancer Ther 7 675 687 10.1586/14737140.7.5.675 1:CAS:528:DC%2BD2sXmvVKqs7Y%3D 17492931 (Pubitemid 46805563)
27. HY Liu EKA Nur M Schachner, et al. 2005 Neurite guidance by the FnC repeat of human tenascin-C: neurite attraction vs. neurite retention Eur J Neurosci 22 1863 1872 10.1111/j.1460-9568.2005.04383.x 16262626 (Pubitemid 41579377)
28. B Riederer A Matus 1985 Differential expression of distinct microtubule-associated proteins during brain development Proc Natl Acad Sci U S A 82 6006 6009 10.1073/pnas.82.17.6006 1:CAS:528:DyaL2MXltl2gsrs%3D 3898077 (Pubitemid 16218891)
29. BM Riederer I Barakat-Walter 1992 Differential distribution of two microtubule-associated proteins, MAP2 and MAP5, during chick dorsal root ganglion development in situ and in culture Brain Res Dev Brain Res 68 111 123 10.1016/0165-3806(92)90253-S 1:CAS:528:DyaK38XlvVymsbY%3D 1521317
30. J Ferralli T Doll A Matus 1994 Sequence analysis of MAP2 function in living cells J Cell Sci 107 Pt 11 3115 3125 1:CAS:528:DyaK2MXisFSktrc%3D 7699010 (Pubitemid 24365215)
31. S Kindler B Schulz M Goedert, et al. 1990 Molecular structure of microtubule-associated protein 2b and 2c from rat brain J Biol Chem 265 19679 19684 1:CAS:528:DyaK3MXhvFKgsw%3D%3D 2174050 (Pubitemid 120013915)
32. N Kalcheva J Albala K O'Guin, et al. 1995 Genomic structure of human microtubule-associated protein 2 (MAP-2) and characterization of additional MAP-2 isoforms Proc Natl Acad Sci U S A 92 10894 10898 10.1073/pnas.92.24.10894 1:CAS:528:DyaK2MXps1amurs%3D 7479905
33. B Shafit-Zagardo P Davies J Rockwood, et al. 2000 Novel microtubule-associated protein-2 isoform is expressed early in human oligodendrocyte maturation Glia 29 233 245 10.1002/(SICI)1098-1136(20000201)29: 3<233::AID-GLIA5>3.0.CO;2-U 1:STN:280:DC%2BD3c7htFWmug%3D%3D 10642750 (Pubitemid 30079172)
34. I Blumcke S Muller R Buslei, et al. 2004 Microtubule-associated protein-2 immunoreactivity: a useful tool in the differential diagnosis of low-grade neuroepithelial tumors Acta Neuropathol (Berl) 108 89 96 10.1007/s00401-004- 0873-8 (Pubitemid 39136293)
35. DN Louis H Ohgaki OD Wiestler, et al. 2007 The 2007 WHO classification of tumours of the central nervous system Acta Neuropathol 114 97 109 10.1007/s00401-007-0243-4 17618441 (Pubitemid 47103521)
36. I Blumcke AJ Becker S Normann, et al. 2001 Distinct expression pattern of microtubule-associated protein-2 in human oligodendrogliomas and glial precursor cells J Neuropathol Exp Neurol 60 984 993 1:CAS:528: DC%2BD3MXns1yrsrw%3D 11589429 (Pubitemid 32924124)
37. Y Yasuda S Fujita 2003 Distribution of MAP1A, MAP1B, and MAP2A&B during layer formation in the optic tectum of developing chick embryos Cell Tissue Res 314 315 324 10.1007/s00441-003-0796-z 1:CAS:528:DC%2BD3sXpt1Wgs7Y%3D 14523640 (Pubitemid 37518632)
38. R Buslei A Holsken B Hofmann, et al. 2007 Nuclear beta-catenin accumulation associates with epithelial morphogenesis in craniopharyngiomas Acta Neuropathol (Berl) 113 585 590 10.1007/s00401-006-0184-3 1:CAS:528: DC%2BD2sXks1ygtLw%3D (Pubitemid 46672605)
39. F Lefranc T Mijatovic C Decaestecker, et al. 2005 Monitoring the expression profiles of integrins and adhesion/growth-regulatory galectins in adamantinomatous craniopharyngiomas: their ability to regulate tumor adhesiveness to surrounding tissue and their contribution to prognosis Neurosurgery 56 763 776 10.1227/01.NEU.0000156788.44397.B4 15792515 (Pubitemid 40489746)
40. F Rotondo K Oniya K Kovacs, et al. 2005 MAP-2 expression in the human adenohypophysis and in pituitary adenomas. An immunohistochemical study Pituitary 8 75 79 10.1007/s11102-005-1523-4 1:CAS:528:DC%2BD28XhvVSrt74%3D 16195780 (Pubitemid 43299784)
41. HL Weiner JH Wisoff ME Rosenberg, et al. 1994 Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome Neurosurgery 35 1001 1010 10.1097/00006123-199412000-00001 1:STN:280:DyaK2M7ptFOmsQ%3D%3D 7885544 discussion 1010-1011
42. TB Crotty BW Scheithauer WF Young Jr 1995 Papillary craniopharyngioma: a clinicopathological study of 48 cases J Neurosurg 83 206 214 10.3171/jns.1995.83.2.0206 1:STN:280:DyaK2MzktFensw%3D%3D 7616262
43. A Hirano R Wate 2007 Diagnostic clues and more from photographs Neuropathology 27 1 9 10.1111/j.1440-1789.2006.00764.x 17319278 (Pubitemid 46146608)
44. T Liszczak EP Richardson Jr JP Phillips, et al. 1978 Morphological, biochemical, ultrastructural, tissue culture and clinical observations of typical and aggressive craniopharyngiomas Acta Neuropathol 43 191 203 1:STN:280:DyaE1M%2Fhsl2guw%3D%3D 696237 (Pubitemid 9023401)
45. N Karavitaki C Brufani JT Warner, et al. 2005 Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up Clin Endocrinol (Oxf) 62 397 409 10.1111/j.1365-2265.2005.02231.x 1:STN:280:DC%2BD2M7nsFOgtA%3D%3D (Pubitemid 40503365)
46. JT Rutka G Apodaca R Stern, et al. 1988 The extracellular matrix of the central and peripheral nervous systems: structure and function J Neurosurg 69 155 170 10.3171/jns.1988.69.2.0155 1:CAS:528:DyaL1cXltVOqtbs%3D 3292716
47. A Giese MD Rief MA Loo, et al. 1994 Determinants of human astrocytoma migration Cancer Res 54 3897 3904 1:STN:280:DyaK2czgs1CjsA%3D%3D 8033113 (Pubitemid 24241213)
48. B Shafit-Zagardo Y Kress ML Zhao, et al. 1999 A novel microtubule-associated protein-2 expressed in oligodendrocytes in multiple sclerosis lesions J Neurochem 73 2531 2537 10.1046/j.1471-4159.1999.0732531.x 1:CAS:528:DyaK1MXns1egsr0%3D 10582615
49. MA Cosenza ML Zhao SL Shankar, et al. 2002 Up-regulation of MAP2e-expressing oligodendrocytes in the white matter of patients with HIV-1 encephalitis Neuropathol Appl Neurobiol 28 480 488 10.1046/j.1365-2990.2002. 00420.x 1:CAS:528:DC%2BD38Xps1yjtLY%3D 12445164 (Pubitemid 35425601)
50. JG Toma M Akhavan KJ Fernandes, et al. 2001 Isolation of multipotent adult stem cells from the dermis of mammalian skin Nat Cell Biol 3 778 784 10.1038/ncb0901-778 1:CAS:528:DC%2BD3MXmvF2lsrk%3D 11533656 (Pubitemid 32842682)
51. SY Kim SH Lee BM Kim, et al. 2004 Activation of nestin-positive duct stem (NPDS) cells in pancreas upon neogenic motivation and possible cytodifferentiation into insulin-secreting cells from NPDS cells Dev Dyn 230 1 11 10.1002/dvdy.20012 1:CAS:528:DC%2BD2cXksVWlsrc%3D 15108304 (Pubitemid 38544068)
52. JM Krum JM Rosenstein 1999 Transient coexpression of nestin, GFAP, and vascular endothelial growth factor in mature reactive astroglia following neural grafting or brain wounds Exp Neurol 160 348 360 10.1006/exnr.1999.7222 1:CAS:528:DC%2BD3cXjtVSgtQ%3D%3D 10619552
53. A Leins P Riva R Lindstedt, et al. 2003 Expression of tenascin-C in various human brain tumors and its relevance for survival in patients with astrocytoma Cancer 98 2430 2439 10.1002/cncr.11796 1:CAS:528: DC%2BD3sXpvFOrt78%3D 14635078 (Pubitemid 37466658)
54. S Sarkar RK Nuttall S Liu, et al. 2006 Tenascin-C stimulates glioma cell invasion through matrix metalloproteinase-12 Cancer Res 66 11771 11780 10.1158/0008-5472.CAN-05-0470 1:CAS:528:DC%2BD28Xhtlagu7%2FF 17178873 (Pubitemid 46094189)
55. K Beiter E Hiendlmeyer T Brabletz, et al. 2005 beta-Catenin regulates the expression of tenascin-C in human colorectal tumors Oncogene 24 8200 8204 1:CAS:528:DC%2BD2MXht1yktbfE 16091738 (Pubitemid 41759818)
56. A Faissner D Steindler 1995 Boundaries and inhibitory molecules in developing neural tissues Glia 13 233 254 10.1002/glia.440130402 1:STN:280:DyaK2MzktVaktg%3D%3D 7615335
57. TF O'Brien A Faissner M Schachner, et al. 1992 Afferent-boundary interactions in the developing neostriatal mosaic Brain Res Dev Brain Res 65 259 267 10.1016/0165-3806(92)90187-2 1373996
58. RS Freeman MC Barone 2005 Targeting hypoxia-inducible factor (HIF) as a therapeutic strategy for CNS disorders Curr Drug Targets CNS Neurol Disord 4 85 92 10.2174/1568007053005154 1:CAS:528:DC%2BD2MXhsVKmtr8%3D 15723616 (Pubitemid 41403317)
59. A Holsken J Kreutzer BM Hofmann, et al. 2009 Target gene activation of the Wnt signaling pathway in nuclear beta-catenin accumulating cells of adamantinomatous craniopharyngiomas Brain Pathol 19 3 357 364 10.1111/j.1750-3639.2008.00180.x 18540944